Home

Diana Brainard, CEO: Kalaris Therapeutics KLRS Sell · Filed 23/08/21

Trade details

Type
Insider sale
Amount
$28,402.5
Shares · price
11,361 sh · $2.50 a share
Held after
895,938 sh
Trade date
23/08/17
Filed
23/08/21
Days to filing
4 days

Sold 1.3% of holdings

Share of holding sold
1.3%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 23/07/18~23/09/16

Diana Brainard's recent trades

  • Diana Brainard

    SellKalaris Therapeutics

    $4,788

    Filed 24/11/20

  • Diana Brainard

    SellKalaris Therapeutics

    $9,124

    Filed 24/11/06

  • Diana Brainard

    SellKalaris Therapeutics

    $7,607

    Filed 24/10/23

  • Diana Brainard

    SellKalaris Therapeutics

    $1,209

    Filed 24/10/04

  • Diana Brainard

    SellKalaris Therapeutics

    $3,989

    Filed 24/08/22

Diana Brainard, CEO — sold $28.4K of Kalaris Therapeutics KLRS · 1.3% of holdings · 10b5-1 plan | Whalegun